Dual role of the Anopheles coluzzii Venus Kinase Receptor in both larval growth and immunity.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
05 03 2019
05 03 2019
Historique:
received:
13
09
2018
accepted:
12
02
2019
entrez:
7
3
2019
pubmed:
7
3
2019
medline:
24
9
2020
Statut:
epublish
Résumé
Vector-borne diseases and especially malaria are responsible for more than half million deaths annually. The increase of insecticide resistance in wild populations of Anopheles malaria vectors emphasises the need for novel vector control strategies as well as for identifying novel vector targets. Venus kinase receptors (VKRs) constitute a Receptor Tyrosine Kinase (RTK) family only found in invertebrates. In this study we functionally characterized Anopheles VKR in the Gambiae complex member, Anopheles coluzzii. Results showed that Anopheles VKR can be activated by L-amino acids, with L-arginine as the most potent agonist. VKR was not required for the fecundity of A. coluzzii, in contrast to reports from other insects, but VKR function is required in both Anopheles males and females for development of larval progeny. Anopheles VKR function is also required for protection against infection by Plasmodium parasites, thus identifying a novel linkage between reproduction and immunity in Anopheles. The insect specificity of VKRs as well as the essential function for reproduction and immunity suggest that Anopheles VKR could be a potentially druggable target for novel vector control strategies.
Identifiants
pubmed: 30837655
doi: 10.1038/s41598-019-40407-x
pii: 10.1038/s41598-019-40407-x
pmc: PMC6401105
doi:
Substances chimiques
Receptor Protein-Tyrosine Kinases
EC 2.7.10.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3615Références
Exp Parasitol. 2012 Sep;132(1):32-9
pubmed: 21616067
Annu Rev Immunol. 2007;25:697-743
pubmed: 17201680
Parasit Vectors. 2016 Sep 15;9(1):504
pubmed: 27628765
J Biol Chem. 2004 Sep 3;279(36):37407-14
pubmed: 15231836
PLoS One. 2009 May 21;4(5):e5651
pubmed: 19461966
BMC Genomics. 2013 May 30;14:361
pubmed: 23721482
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19631-6
pubmed: 19060216
Mol Biochem Parasitol. 2004 Sep;137(1):23-33
pubmed: 15279948
Nature. 2015 Oct 8;526(7572):207-211
pubmed: 26375008
Biopolymers. 2005;80(2-3):357-66
pubmed: 15810013
Mol Biochem Parasitol. 2003 Jan;126(1):51-62
pubmed: 12554084
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Eur J Biochem. 2000 Oct;267(20):6256-63
pubmed: 11012680
Parasit Vectors. 2017 Sep 19;10(1):429
pubmed: 28927428
Zootaxa. 2013;3619:246-74
pubmed: 26131476
Lancet. 2016 Apr 23;387(10029):1785-8
pubmed: 26880124
Semin Cancer Biol. 1997 Apr;8(2):83-92
pubmed: 9299586
PLoS One. 2013 Dec 04;8(12):e79861
pubmed: 24324583
J Biol Chem. 2006 Oct 6;281(40):29513-24
pubmed: 16899460
PLoS Pathog. 2014 May 29;10(5):e1004138
pubmed: 24875530
Curr Drug Targets. 2007 Jan;8(1):169-84
pubmed: 17266540
Pharmacol Ther. 2003 Jun;98(3):325-54
pubmed: 12782243
Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5057-62
pubmed: 25848040
PLoS Pathog. 2009 Apr;5(4):e1000366
pubmed: 19343212
PLoS Pathog. 2013;9(9):e1003622
pubmed: 24039583
Dev Comp Immunol. 2016 Feb;55:119-29
pubmed: 26515540
Sci Rep. 2017 Sep 15;7(1):11730
pubmed: 28916758
Annu Rev Entomol. 2013;58:497-516
pubmed: 23072462